
Journal of Medicinal Chemistry p. 4195 - 4204 (1992)
Update date:2022-08-03
Topics:
Deal, Martyn J.
Hagan, Russell M.
Ireland, Simon J.
Jordan, Christopher C.
McElroy, Andrew B.
et al.
The design and synthesis of potent and selective neurokinin NK-2 receptor agonists 12 (GR64349) and 31 are described, together with structure-activity relationships for related analogues.Compound 12 (EC50 = 3.7 nM at NK-2 receptors in the rat colon; selectivity >1000- and >300-fold with respect to NK-1 and NK-3 receptors, respectively) was derived by incorporation of a Gly-Leu γ-lactam conformational constraint into the C-terminal region of the neurokinin A octapeptide analogue
Hangzhou JINLAN Pharm-Drugs Technology Co., Ltd
website:http://www.jlpharms.com
Contact:86-571-86982636
Address:Rm A606, Fuyi Center, jianqiao street
Wuhan Benjamin Pharmaceutical Chemical Co.,Ltd
Contact:86-27-52341789
Address:Room 1518 B suite, optical valley time square, No 111 Guanshan Road, Hongshan District,Wuhan,Hubei Province,China.
Beijing Stable Chemcial Co.ltd
Contact:86-10-63785052
Address:A1301 Technological Edifice. No.4 FuFeng Road,FengTai District, Beijing. China
Shanghai Zhihua ChemTech Co., Ltd.
Contact:+86-13774313779
Address:Room 817 Suite B 3333 Shenjiang Road
website:http://www.afinechem.com
Contact:+86-571-85134551
Address:No. 206 Zhen Hua Road, Hangzhou 310030, Zhejiang, China
Doi:10.1002/hlca.19750580418
(1975)Doi:10.1016/S0040-4020(01)88305-8
(1992)Doi:10.1016/S0040-4039(00)74815-5
(1992)Doi:10.1016/j.molliq.2013.01.013
(2013)Doi:10.1021/jo4005684
(2013)Doi:10.1055/s-1992-26201
(1992)